 |  |
Treatment Action Group and Stop TB Partnership Satellite Workshop
on MDR- and XDR-TB in the Context of HIV Infection
November 6, 2007. Cape Town, South Africa. Satellite Agenda
Note: powerpoint format requires viewer. Download Powerpoint Viewer for free.
| Time | Topic | Speaker |
| 9-9:15 am | Coffee and Registration | |
| 9:15-9:50 am | Opening talks to set the stage on the emergence of M/XDR-TB and the need for new thinking; TB/HIV collaborative activities & civil society from an activist, National TB, and WHO perspective (10 mins each) | Haileyesus Getahun, WHO, Rhehab Chimzizi, Malawi National TB Program, Zackie Achmat, TAC |
| 9:50-11:40 am | Panel 1: The Emergence and Prevention of MDR- and XDR-TB | Alasdair Reid, UNAIDS, Chair |
| Global response plan for MDR- and XDR-TB (15 min) | Ernesto Jaramillo, WHO | |
| Impact of M/XDR on TB/HIV coinfected individuals and communities (15 min) | Neel Gandhi, Montefiore Hospital, USA | |
| How NTPs can prevent and manage DR TB. (15 min) | Carmelia Basri, TB Program, Indonesia | |
| Community based treatment support and case detection strategies and how can they prevent and address DR TB (15 min) | Boniswa Seti, TAC, South Africa | |
| Discussion & Future Directions (10 min each) | Pheello Lethola, MSF-Lesotho; Jaime Bayona, Socios en Salud, Peru | |
| Q&A and Wrap Up (30 min) | Chair | |
| 11:40-12:40 pm | Lunch will be provided | |
| 12:40- 2:30 pm | Panel 2: Scaling up M/XDR Diagnostics & Treatment: Addressing the Bottlenecks | Carole Mitnick, Partners in Health, Chair |
| Lab Capacity Strengthening: What is being done? (15 min) | Abigail Wright, WHO | |
| Funding mechanisms for Second-Line TB Drugs (15 min) | Carole Nyirenda, UNITAID | |
| How can countries/sites increase the success of their GLC applications? (15 min) | Hind Satti, Partners in Health, Lesotho | |
| Discussion and Future Directions (10 min each) | Robert Matiru, WHO; Eric Goemaere, MSF-Khayelitsha | |
| Q&A and wrap up (30 min) | Chair | |
| 2:30-2:45 pm | Break | |
| 2:45-4:35 pm | Panel 3: TB Research & Development: Strategies to Move Forward | Elsa Villarino, Chair |
| Current TB Diagnostics Research (15 min) | Richard O'Brien, FIND | |
| Current TB Treatment Research (15 min) | Mel Spigelman, TB Alliance | |
| Strategies to Expedite DR TB R&D: Tibotec Experience (15 min) | David McNeeley, Tibotec/J&J | |
| Beyond Market Forces: Creating New Incentives for TB R&D (15 min) | Tido von Schoen-Angerer, MSF | |
| Discussion and Future Directions (10 min each) | Ezio Santos Filho, Brazil; Ruth McNerney, London School of Tropical Medicine | |
| Q&A and wrap up (30 min) | Chair | |
| 4:35-5 pm | Summary and Future Directions | Olayide Akanni, JAAIDS; Mark Harrington, TAG; Umesh Lalloo, Nelson Mandela School of Medicine SA |
| 5-6 pm | Informal Reception and Discussion Hour | |
Treatment Action Group
611 Broadway, Ste. 308
New York, NY 10012
phone: (212) 253-7922
fax: (212) 253-7923
copyright © 2008 TAG